“There is no one-size-fits-all approach when it comes to fertility care. Every treatment plan should be customized to specifically suit each woman’s body and based on individual needs. I strongly believe that everyone has the right to access fertility care, regardless of their age, ovarian reserve, or financial status. “
— Dr. Jie Deng
Stanford University – Reproductive Endocrinology & Infertility (REI) fellowship
Yale University – Maternal Fetal Medicine (MFM) fellowship
Detroit Medical Center, Wayne State University – Obstetrics & Gynecology residency
Zhongshan University, Guangzhou, China – M.D., Ph.D.
1. Deng J, Zhao QY, Behr B, et al. (2021) The impact of fertilization modality to aneuploidy. Fertility & Sterility Report February 2021.
2. Deng J, Hong H, Zhao QY, et al. (2020) Preimplantation genetic testing for aneuploidy in poor ovarian responders with four or fewer eggs retrieved. Journal of Assisted Reproductive Genetics. 37(5): 1147–1154.
3. Deng J, Zhao QY, Cinnioglu C, et al. (2020) The impact of culture conditions on blastocyst formation and aneuploidy rates: a comparison between single-step and sequential media in a large academic practice. Journal of Assisted Reproductive Genetics. 37(1): 161-169.
4. Deng J, Mueller M, Geng T, et al. (2017) H19 lncRNA-induced epigenetic programming of hepatic gluconeogenic gene expression in metformin exposed fetus. H19 lncRNA alters methylation and expression of Hnf4α in the liver of metformin-exposed fetuses. Cell Death Dis. 7;8(12).
5. Deng J, Peng WL, Li J et al. (2006) Successful Preimplantation genetic diagnosis for alpha-and beta-thalassemia in China. Prenatal Diagnosis, 26(11): 1021-1028.
What we specialize in
Dr. Deng relocated to the United States in 2008 where she was awarded a California Institute of Regenerative Medicine research Grant and worked in the field of stem cell research at University of California in San Diego. Subsequently, Dr. Deng completed her residency in Obstetrics and Gynecology at Detroit Medical Center, Wayne State University.
After residency she was trained and worked as a Maternal-fetal Medicine (MFM) specialist at Yale University. The experience in the MFM field provided Dr. Deng vast special knowledge and skills in high-risk pregnancy care, which attracted many advanced age high risk infertility patients. When Dr. Deng was at Stanford University REI fellowship program, she observed limitations of conventional IVF in many women, and she has been actively applying individualized fertility treatment including ‘Mild-IVF’ to her patients and achieved pregnancies in otherwise ‘hopeless cases’.
Dr. Deng is also fully trained as an embryologist and is currently one of a handful of reproductive endocrinologists in the United States to be certified as a High Complexity Lab Director (H.C.L.D.) in Embryology. Her unique background and expertise with the clinical and embryology laboratory provide Dr. Deng with the extensive skill and knowledge that are necessary in treating challenging fertility cases.
Dr. Deng is a physician scientist. She published a variety of peer-reviewed articles in the fields of reproductive health, genetics, epigenetics, and stem cells in journals such as Nature Medicine, Nature Genetics, Nature Methods, Fertility & Sterility, Journal of Assisted Reproduction and Genetics, Molecular Human Reproduction, Prenatal Diagnosis, Genome Research, Cell Stem Cell and Molecular Cells.
Fellowship – Reproductive Endocrinology & Infertility, Stanford Reproductive & Fertility Health, Sunnyvale, CA USA
Fellowship – Maternal Fetal Medicine, Yale New Haven Hospital, New Haven, CT USA
Residency – Obstetrics and Gynecology, Detroit Medical Center, Wayne state university, Detroit, MI USA
Research Fellow – California Institute of Regenerative Medicine (CIRM), Bioengineering
Department, University of California in San Diego, La Jolla, CA USA
M.D., Ph.D. – Zhongshan University (Sun Yat-Sen University of Medical Sciences), Guangzhou, China